抗胆碱能药物

新型选择性抗胆碱能药物作为支气管扩张剂在COPD治疗中发挥了重要的作用。

As bronchodilators , new type selective anticholinergics play an important role in the treatment of COPD .

结论COPD患者吸入抗胆碱能药物与发生心血管死亡，心肌梗死或卒中危害增高有关。

Conclusion Inhaled anticholinergics are associated with a significantly increased risk of cardiovascular death , MI , or stroke among patients with COPD .

糖皮质激素和抗胆碱能药物对慢性阻塞性肺疾病大鼠模型肺组织腺苷A1受体表达的影响

Expression of adenosine receptor A1 in the rats model of chronic obstructive pulmonary disease could be suppressed by inhaled corticosteroid and anticholinergic agents

结果及结论：抗胆碱能药物、茶碱药物和祛痰药都是临床应用较多的药物，抗胆碱能药物多用于治疗COPD和哮喘，剂量小，持续时间长，不良反应少。

RESULTS CONCLUSION : Anticholinergic agents , theoclears and expectorants were frequently used in the clinic . Anticholinergic agents were chiefly used for COPD and asthma at low dose yet with long duration and few adverse drug reactions .

本文就正常人肺脏的植物神经及其受体、COPD患者胆碱能神经及受体的变化、受体高选择性抗胆碱能药物在COPD治疗中应用的进展进行综述。

The article reviews the lung 's autonomic nerve and its receptors in healthy human beings , the changes of cholinergic nerve and its receptors in COPD patients , and the advances of the high selective anticholinergics in the treatment of COPD .

结果发现，年龄、性别、抗胆碱能药物、用药总时间和目前用药量等五个因素在0.05或0.01水平上对TES的存在有显著意义上的作用。

It was found suggest that age , gender , anticholinergic drugs , treatment duration and current dosage as the risk factors have significant effects on the existence of TES at 0.05 or 0.01 level .

抗胆碱能药物分子烙印聚合物的色谱行为研究

Study on HPLC Behavior of Anticholinergic Drugs by Molecularly Imprinted Polymers

抗胆碱能药物可以抑制支气管平滑肌收缩。

Anti-cholinergic drugs could inhibit bronchial smooth muscle to contract .

非水毛细管电泳拆分抗胆碱能药物对映体

Chiral Separation System of Anticholinergic Drugs in Nonaqueous Capillary Electrophoresis

联合使用抗胆碱能药物16例，出现药物不良反应28例。

Sixteen combined anti - choline , and 28 had adverse reactions .

抗胆碱能药物能提高膀胱顺应性和排尿节制功能。

Anti-cholinesterase could improve the compliance and uresis rhythm of the neurogenic bladder .

选择性抗胆碱能药物治疗慢性阻塞性肺疾病的研究进展

Research advances of selective anticholinergics in the treatment of chronic obstructive pulmonary disease

行为治疗无效的急迫性尿失禁患儿行抗胆碱能药物治疗有效率达81%（22／27）。

The effective rate of anticholinergic therapy was 81 % ( 22 / 27 ) .

抗胆碱能药物具有辅助治疗作用。

Drug is only assistant treatment .

老年人群的非退行性轻度认知功能损害和抗胆碱能药物应用的纵向队列研究

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs : Longitudinal cohort study

目的建立非水毛细管电泳拆分体系拆分抗胆碱能药物。

Aim To establish a chiral separation system in nonaqueous capillary electrophoresis to separate anticholinergic drugs .

抗胆碱能药物的构象研究Ⅰ.阿托品类茄科生物碱的分子力学研究

Conformational analysis on anticholinergic drugs ⅰ . molecular mechanics MMPM calculation of atropine and other alkaloids in the belladonna plant

目的：观察β2受体激动剂硫酸特布他林和抗胆碱能药物溴化异丙托品联合雾化吸入治疗哮喘急性发作的作用。

Objective : To observe the effect of aerosol inhalation of β 2 receptor stimulant combined with anticholinergic in treating asthma attack .

目的研究抗胆碱能药物解磷复方和红景天对低压缺氧复合梭曼中毒大鼠脑损伤的作用效果。

Objective To investigate the effects of anticholinergic antidote and rhodosin on the brain injury induced by soman intoxication combined with hypobaric hypoxia in rats .

抗胆碱能药物是一类重要的外周神经系统药物，它能阻滞胆碱受体，使递质乙酰胆碱不能与受体结合。

Anticholinergic drugs are a class of important peripheral nervous system drugs , which block cholinergic receptors , so that neurotransmitter acetylcholine receptor-binding and should not .

激动剂、抗胆碱能药物、糖皮质激素是治疗重症哮喘的主要药物，正确应用可以使绝大部分患者得到缓解，并避免使用机械通气。

Beta-agonists , anticholinergics , and corticosteroids are the bases of the drug therapy , proper uses of these drugs can relieve conditions significantly in most patients .

结果表明，根据胆碱酯酶活性的变化，正确应用抗胆碱能药物和胆碱酯酶复能剂对预防反跳意义重大。

The result indicates that according to the changes of cholinesterase activity , it is important to use anticholinergic drugs and cholinesterase reactivators correctly for preventing poisoning rebound .

前言：目的：评价抗胆碱能类药物和茶碱制剂以及祛痰药的临床应用情况。

OBJECTIVE : To evaluate the application of anticholinergic agents , theoclears and expectorants in the clinic .

患儿均进行系统行为和抗感染治疗，对初期治疗效果不理想的急迫性尿失禁患儿加用抗胆碱能药物治疗。

Treatment included behavioral therapy and anti-infective therapy in all children .